XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2022 $ 4,084,649 $ 28 $ 119,731,764 $ (115,647,143)
Beginning Balance, Shares at Dec. 31, 2022   278,558    
Stock-based compensation expense 284,572   284,572  
Net loss (2,243,070)     (2,243,070)
Ending Balance at Mar. 31, 2023 2,126,151 $ 28 120,016,336 (117,890,213)
Ending Balance, Shares at Mar. 31, 2023   278,558    
Beginning Balance at Dec. 31, 2022 4,084,649 $ 28 119,731,764 (115,647,143)
Beginning Balance, Shares at Dec. 31, 2022   278,558    
Net loss (5,804,894)      
Ending Balance at Sep. 30, 2023 (873,775) $ 28 120,578,234 (121,452,037)
Ending Balance, Shares at Sep. 30, 2023   278,558    
Beginning Balance at Mar. 31, 2023 2,126,151 $ 28 120,016,336 (117,890,213)
Beginning Balance, Shares at Mar. 31, 2023   278,558    
Stock-based compensation expense 280,140   280,140  
Net loss (1,867,917)     (1,867,917)
Ending Balance at Jun. 30, 2023 538,374 $ 28 120,296,476 (119,758,130)
Ending Balance, Shares at Jun. 30, 2023   278,558    
Stock-based compensation expense 281,758   281,758  
Net loss (1,693,907)     (1,693,907)
Ending Balance at Sep. 30, 2023 (873,775) $ 28 120,578,234 (121,452,037)
Ending Balance, Shares at Sep. 30, 2023   278,558    
Beginning Balance at Dec. 31, 2023 $ (2,579,537) $ 28 120,859,873 (123,439,438)
Beginning Balance, Shares at Dec. 31, 2023 278,558 278,558    
Stock-based compensation expense $ 254,029   254,029  
Issuance of common stock, Pre-Funded Warrants, Series A Warrants, Series B Warrants, and Series C Warrants net of issuance costs 6,172,623 $ 43 6,172,580  
Issuance of common stock, Pre-Funded Warrants, Series A Warrants, Series B Warrants, and Series C Warrants net of issuance costs, shares   427,886    
Amendment and issuance of common stock from Amendment of Series B Warrants and Series C Warrants, net of issuance costs 1,229,874 $ 1 1,229,873  
Amendment and issuance of common stock from Amendment of Series B Warrants and Series C Warrants, net of issuance costs, shares   9,967    
Net loss (1,579,820)     (1,579,820)
Ending Balance at Mar. 31, 2024 3,497,169 $ 72 128,516,355 (125,019,258)
Ending Balance, Shares at Mar. 31, 2024   716,411    
Beginning Balance at Dec. 31, 2023 $ (2,579,537) $ 28 120,859,873 (123,439,438)
Beginning Balance, Shares at Dec. 31, 2023 278,558 278,558    
Net loss $ (4,159,428)      
Ending Balance at Sep. 30, 2024 $ 4,387,136 $ 89 131,985,913 (127,598,866)
Ending Balance, Shares at Sep. 30, 2024 894,843 894,843    
Beginning Balance at Mar. 31, 2024 $ 3,497,169 $ 72 128,516,355 (125,019,258)
Beginning Balance, Shares at Mar. 31, 2024   716,411    
Stock-based compensation expense 126,578   126,578  
Amendment and issuance of common stock from Amendment of Series B Warrants and Series C Warrants, net of issuance costs 308,429   308,429  
Issuance of common stock from cashless exercise of pre-funded warrants   $ 1 (1)  
Issuance of common stock from cashless exercise of pre-funded warrants, Shares   18,425    
Net loss (1,267,218)     (1,267,218)
Ending Balance at Jun. 30, 2024 2,664,958 $ 73 128,951,361 (126,286,476)
Ending Balance, Shares at Jun. 30, 2024   734,836    
Stock-based compensation expense 131,587   131,587  
Amendment and issuance of common stock from Amendment of Series B Warrants and Series C Warrants, net of issuance costs 2,532,449 $ 3 2,532,446  
Amendment and issuance of common stock from Amendment of Series B Warrants and Series C Warrants, net of issuance costs, shares   24,509    
Amendment and issuance of common stock from Exercise Price Warrant Amendment of Series A Warrants and Series Warrants, net of issuance costs 370,622 $ 5 370,617  
Amendment and issuance of common stock from Exercise Price Warrant Amendment of Series A Warrants and Series Warrants, net of issuance costs, shares   51,062    
Issuance of common stock from cashless exercise of pre-funded warrants 101 $ 8 93  
Issuance of common stock from cashless exercise of pre-funded warrants, Shares   84,436    
Redemption of fractional shares due to reverse stock split (191)   (191)  
Net loss (1,312,390)     (1,312,390)
Ending Balance at Sep. 30, 2024 $ 4,387,136 $ 89 $ 131,985,913 $ (127,598,866)
Ending Balance, Shares at Sep. 30, 2024 894,843 894,843